These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28647324)

  • 1. AMPK as a Therapeutic Target for Treating Metabolic Diseases.
    Day EA; Ford RJ; Steinberg GR
    Trends Endocrinol Metab; 2017 Aug; 28(8):545-560. PubMed ID: 28647324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
    Gugliucci A
    Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
    Sáez-Lara MJ; Robles-Sanchez C; Ruiz-Ojeda FJ; Plaza-Diaz J; Gil A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.
    Xiong XQ; Geng Z; Zhou B; Zhang F; Han Y; Zhou YB; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Metabolism; 2018 Jun; 83():31-41. PubMed ID: 29374559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
    Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
    PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Energy Sensing and Metabolism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture.
    Steinberg GR
    Diabetes; 2018 Feb; 67(2):169-179. PubMed ID: 29358486
    [No Abstract]   [Full Text] [Related]  

  • 10. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus.
    Wang D; Yang L; Liu Y
    Curr Drug Targets; 2022; 23(11):1057-1071. PubMed ID: 36028937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.
    Shepard CR
    Front Endocrinol (Lausanne); 2020; 11():613639. PubMed ID: 33584545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
    Gastaldelli A
    Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.
    Hegarty BD; Turner N; Cooney GJ; Kraegen EW
    Acta Physiol (Oxf); 2009 May; 196(1):129-45. PubMed ID: 19245658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK, insulin resistance, and the metabolic syndrome.
    Ruderman NB; Carling D; Prentki M; Cacicedo JM
    J Clin Invest; 2013 Jul; 123(7):2764-72. PubMed ID: 23863634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunometabolism of AMPK in insulin resistance and atherosclerosis.
    Fullerton MD; Steinberg GR; Schertzer JD
    Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nonalcoholic fatty liver disease: role of AMPK.
    Smith BK; Marcinko K; Desjardins EM; Lally JS; Ford RJ; Steinberg GR
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E730-E740. PubMed ID: 27577854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions.
    Cusi K
    Diabetologia; 2016 Jun; 59(6):1112-20. PubMed ID: 27101131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.
    Karunakaran D; Richards L; Geoffrion M; Barrette D; Gotfrit RJ; Harper ME; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2536-43. PubMed ID: 26427794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.